Neural Analytics, Inc. to Present at Needham & Company’s 17th Annual Healthcare Conference
March 22 2018 - 7:35AM
Business Wire
Neural Analytics, Inc., a medical device company developing and
commercializing technologies to measure, diagnose and track brain
health, today announced that Anjan Chatterji, Executive Vice
President of Corporate Development and Strategy, and Henry Hewes,
Vice President of Sales and Global Marketing, will present at the
Needham & Company's 17th Annual Healthcare Conference on
Wednesday, March 28, 2018 at 9 a.m. EDT, at the Westin Grand
Central Hotel in New York. They will discuss the commercial and
capital goals of the company since its recent closing of a $15M
Series B financing.
About Neural Analytics, Inc.
Neural Analytics, Inc. was founded in 2013 to create products
and services to measure, diagnose and track brain health. The
company’s current focus is on acute ischemic stroke, traumatic
brain injury and dementia. They combine leading data science with
cutting edge hardware to allow first responders and clinicians to
accurately assess and monitor brain health issues. Their devices
are designed to be portable, autonomous, reliable and produce
precise and objective physiological measurements for medical
responder monitoring of neural disorders.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180322005287/en/
Investors:Neural Analytics, Inc.Artin DavidianDirector of
FP&AArtin.Davidian@NeuralAnalytics.comorMedia:Lazar
Partners for Neural Analytics, Inc.Erich Sandoval,
+1-917-497-2867esandoval@lazarpartners.com